↓ Skip to main content

Dove Medical Press

Article Metrics

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
17 Mendeley
Title
Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use
Published in
Therapeutics and Clinical Risk Management, October 2018
DOI 10.2147/tcrm.s157171
Pubmed ID
Authors

Diego Jose Maselli, Linda Rogers, Jay I Peters

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 35%
Other 2 12%
Lecturer 1 6%
Student > Ph. D. Student 1 6%
Student > Master 1 6%
Other 1 6%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Biochemistry, Genetics and Molecular Biology 2 12%
Business, Management and Accounting 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 6 35%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2018.
All research outputs
#3,983,244
of 13,887,828 outputs
Outputs from Therapeutics and Clinical Risk Management
#223
of 994 outputs
Outputs of similar age
#119,494
of 317,837 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 7 outputs
Altmetric has tracked 13,887,828 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 994 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,837 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them